Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: PRA023 IV Low Dose
Total 0 results
Nothing found
Sponsors and Collaborators
Dermatologic Surgery Center of Washington LLC and Skin Cancer Treatment Center
HMO Gesundheitsplan Basel, Switzerland
London Metropolitan University
Peijas Hospital
Gynea Laboratorios SA
delta medical promotions ag
Stefano Rizza
Washington State Attorney General's Office
Pedro Rodrigues Genta
Advanced Reconstructive Surgery Alliance
WillowWood Global LLC
IRCCS San Raffaele Roma
Marealis AS
mHealth Impact Lab
Hoffmann-La Roche
Center for HIV/AIDS Vaccine Immunology
the Regional Direction of Clinical Research
Nuseed Americas Inc.
Hangzhou Neoantigen Therapeutics Co., Ltd.
Universidad de Chile (UChile, Chile)
View Full List
Medical Conditions
ERYTHROCYTOSIS
Hyperhidrosis Primary Focal Axilla
Apgar; 0-3 at 1 Minute
Hyperthyroid
Charcot-Marie-Tooth Disease Type 2U (Diagnosis)
Urinary System Stones
Flatulence
Non-Hodgkin's Lymphoma (NHL) or Hodgkin's Disease (HD) in 2nd or Greater Complete Remission, Partial Remission
Urosepsis
Cervical Spondylotic Myelopathy
Survivors of Childhood Cancer
Midgut Carcinoid Tumor
PURPURA
Unrestricted Arm Movement
CHD - Coronary Heart Disease
Varicocele Grade III
Amniotic Fluid Leakage
Hermansky Pudlak Syndrome
Tonsil Disease
Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
View Full List
Drug Interventions
Bictegravir (BIC) plus Emtricitabine (FTC) plus Tenofovir Alafenamide (TAF)
MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate (q1w regimen)
RhGM-CSF
Immediate-release nicotinamide (SAD)
Active Comparator: TU2670 320mg
Neridronate
Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets
Simvastatin
Rituxumab
Atorvastatin
Vincristine
Etoposide
Ibrutinib
BIC/FTC/TAF
Silymarin (Silybum marianum)
Metronidazole
Amivantamab
Delamanid
Basiliximab
Yohimbine hydrochloride
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Belgium
Contract Research Organizations in Croatia
Contract Research Organizations in Georgia
Contract Research Organizations in Jordan
Contract Research Organizations in Lithuania
Contract Research Organizations in Malaysia
Contract Research Organizations in Papua New Guinea
Contract Research Organizations in Paraguay
Contract Research Organizations in Slovenia
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Switzerland
Contract Research Organizations in Togo
CRO list by country
CROs in Trinidad & Tobago
SGS
All CROs in Trinidad & Tobago
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe